Yoon, J.-H.; Kim, S.-E.; Cho, S.-H.; Kim, G.-A.; Park, Y.; Park, J.-W.; Kang, S.-H.; Lee, Y.-S.; Kim, J.-H.
Prognosis of Patients with Chronic Hepatitis C Genotype 1b Infection Treated Using Daclatasvir/Asunaprevir after Sustained Virologic Response: A 6-Year Multicenter Prospective Observational Study. Medicina 2023, 59, 1436.
https://doi.org/10.3390/medicina59081436
AMA Style
Yoon J-H, Kim S-E, Cho S-H, Kim G-A, Park Y, Park J-W, Kang S-H, Lee Y-S, Kim J-H.
Prognosis of Patients with Chronic Hepatitis C Genotype 1b Infection Treated Using Daclatasvir/Asunaprevir after Sustained Virologic Response: A 6-Year Multicenter Prospective Observational Study. Medicina. 2023; 59(8):1436.
https://doi.org/10.3390/medicina59081436
Chicago/Turabian Style
Yoon, Jae-Hyun, Sung-Eun Kim, Su-Hyeon Cho, Gi-Ae Kim, Yewan Park, Ji-Won Park, Seong-Hee Kang, Young-Sun Lee, and Jeong-Han Kim.
2023. "Prognosis of Patients with Chronic Hepatitis C Genotype 1b Infection Treated Using Daclatasvir/Asunaprevir after Sustained Virologic Response: A 6-Year Multicenter Prospective Observational Study" Medicina 59, no. 8: 1436.
https://doi.org/10.3390/medicina59081436
APA Style
Yoon, J.-H., Kim, S.-E., Cho, S.-H., Kim, G.-A., Park, Y., Park, J.-W., Kang, S.-H., Lee, Y.-S., & Kim, J.-H.
(2023). Prognosis of Patients with Chronic Hepatitis C Genotype 1b Infection Treated Using Daclatasvir/Asunaprevir after Sustained Virologic Response: A 6-Year Multicenter Prospective Observational Study. Medicina, 59(8), 1436.
https://doi.org/10.3390/medicina59081436
